Gene therapy for hemophilia B represents a groundbreaking shift in how we approach hemophilia treatment, offering hope to thousands battling this genetically inherited disorder.With innovative solutions like Hemgenix gaining FDA approval, patients now have an opportunity to overcome the limitations of traditional therapies that require regular clotting factor infusions.